Healthcare Deals This Week: Sofinnova, Lilly, AbbVie
By Yeji Jesse Lee · March 4, 2025, 6:01 PM EST
It was a busy week for life science dealmaking, with Eli Lilly announcing that it was setting aside $27 billion for U.S. manufacturing, then inking a blockbuster agreement in the molecular glue...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login